HALIFAX, Nova Scotia--(EON: Enhanced Online News)--After one of her most famed patients experienced menopausal palpitations, Dr. Annabelle Volgman ordered an echocardiogram, blood pressure tests and an EKG. The diagnosis was that she was free from blockages; however Dr. Volgman cautioned her that she needed to change her habits. That was in 2001 and the patient was Oprah Winfrey. Dr. Volgman helped build a regimen for a better diet coupled with more exercise and the result was a dramatic change in the award winning talk show host’s lifestyle and health.
“Annabelle Volgman is a leader in the battle against heart disease and we’re thrilled to welcome her to BioPort Atlantic”
Volgman, acclaimed physician, professor of medicine and medical director of the Heart Centre for Women at Rush University Medical Centre in Chicago and cardiologist to the stars will be the keynote speaker at BioPort Atlantic, the region’s premier annual life sciences conference, slated for October 10 in Halifax, NS.
Dr. Volgman is very active in efforts to increase awareness of heart disease in women and has been a prominent leader of the Go Red for Women movement. She has received numerous awards from Rush University Medical Centre, American Heart Association, Girls in the Game and the Asian American Hall of Fame and has been on several Top Doctors lists including the last five years of Chicago Magazine, as well as a Top Doctor for Women in the field of Cardiology by Women's Health Magazine. In 2011 she received the Coeur d'Or Award at the American Heart Association Heart Ball.
“Annabelle Volgman is a leader in the battle against heart disease and we’re thrilled to welcome her to BioPort Atlantic,” said Marli MacNeil, CEO of BioNova, the host of BioPort Atlantic. “On the one hand, many of our member companies’ technologies intersect with cardiac health and on the other, our members, their staffs and their families all need information on how to stay healthy.” MacNeil added, “We expect Dr. Volgman’s passion for her work and her patients will be both informative and inspiring.”
Dr. Volgman's current interests include preventive and management strategies of atrial fibrillation, especially antiarrhythmic drugs and anticoagulants for the prevention of stroke in atrial fibrillation. She is an active member of the American Heart Association, American College of Cardiology and the Heart Rhythm Society.
Dr. Volgman’s presentation is one of the several planned for this year’s BioPort Atlantic conference. Built around the theme BOLD IDEAS for BIG OPPORTUNITIES, the program will feature panel discussions on getting new technologies into the healthcare system, financing, and hearing from top student researchers from around the Atlantic region about their work and plans for the future.
The keynote address will be delivered at the conference luncheon, 12:00 pm on Thursday October 10 at the Westin Nova Scotian. For ticket and registration information, visit bioportatlantic.ca
BioNova is Nova Scotia’s life sciences association, representing companies working in pharmaceuticals/vaccines, medical technologies, natural health products/ nutraceuticals, digital health and bioproducts, as well as research organizations, service providers and other suppliers. More information on BioNova and its members can be found at www.bionova.ca.
About BioPort Atlantic:
BioPort Atlantic is the premier annual life sciences industry event in Atlantic Canada. Since 2002, BioPort has provided a forum to inform and inspire the life sciences community to develop their ideas, commercialize their technologies and build links within the region and with guests brought in from the US and from around the world. More information can be found at www.bioportatlantic.ca